Tropicamide

Do not take it if

Quoted from the official label, section “Contraindications”.

How to take it

These directions are for this exact strength and form. Another one is different.

• For refraction, one or two drops of the 1% solution in the eye(s), repeated in five minutes.
• If patient is not seen within 20 to 30 minutes, an additional drop may be instilled to prolong mydriatic effect.
• For examination of fundus, one or two drops of the 0.5% solution 15 or 20 minutes prior to examination.
• Individuals with heavily pigmented irides may require higher strength or more doses.
• Mydriasis will reverse spontaneously with time, typically in 4 to 8 hours.
• However, in some cases, complete recovery may take up to 24 hours.

Quoted from the official label, section “Dosage & Administration”.

Other warnings

Quoted from the official label, section “Warnings”.

Pregnancy and breastfeeding

Quoted from the official label, section “OTC — Pregnancy or Breast Feeding”.

Other medicines

Quoted from the official label, section “Drug Interactions”.

Use in children

• Tropicamide may rarely cause CNS disturbances which may be dangerous in pediatric patients.
• Psychotic reactions, behavioral disturbances, and vasomotor or cardiorespiratory collapse in children have been reported with the use of anticholinergic drugs (see WARNINGS ).
• Keep this and all medications out of the reach of children.

Quoted from the official label, section “Pediatric Use”.

Use in older people

No overall differences in safety or effectiveness have been observed between elderly and younger patients.

Quoted from the official label, section “Geriatric Use”.

Side effects

• Ocular Transient stinging, blurred vision, photophobia and superficial punctate keratitis have been reported with the use of tropicamide.
• Increased intraocular pressure has been reported following the use of mydriatics.
• Non-Ocular Dryness of the mouth, tachycardia, headache, allergic reactions, nausea, vomiting, pallor, central nervous system disturbances and muscle rigidity have been reported with the use of tropicamide.
• Psychotic reactions, behavioral disturbances, and vasomotor or cardiorespiratory collapse in children have been reported with the use of anticholinergic drugs.
• To report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated at 1-800-553-5340 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Quoted from the official label, section “Adverse Reactions”.

What to discuss with your doctor

• Do not touch dropper tip to any surface, as this may contaminate the solution.
• Patients should be advised not to drive or engage in potentially hazardous activities while pupils are dilated.
• Patients may experience sensitivity to light and should protect eyes in bright illumination during dilation.
• Parents should be warned not to get this preparation in their child’s mouth and wash their own hands and the child’s hands following administration.

Quoted from the official label, section “Patient Counseling Information”.

What it looks like and how it is packed

• Tropicamide ophthalmic solution USP, 1% is supplied in a plastic bottle with a red cap and a controlled drop tip in the following sizes:
• NDC 24208-585-59:
• 2 mL in a 7.5 mL bottle NDC 24208-585-64:
• 15 mL in a 15 mL bottle Tropicamide ophthalmic solution USP, 0.5% is supplied in a plastic bottle with a red cap and a controlled drop tip in the following size:
• NDC 24208-590-64:
• 15 mL in a 15 mL bottle Storage:
• Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
• Keep container tightly closed.
• Keep out of reach of children.
• Distributed by: Bausch & Lomb Americas Inc.
• Bridgewater, NJ 08807 USA Manufactured by:
• Bausch & Lomb Incorporated Tampa, FL 33637 USA © 2023 Bausch & Lomb Incorporated or its affiliates Revised:
• September 2023 9115807 (Folded) 9115907 (Flat) donotuse

Quoted from the official label, section “How Supplied”.

What is in it

• Tropicamide ophthalmic solution, USP is an anticholinergic prepared as a sterile topical ophthalmic solution in two strengths.
• The active ingredient is represented by the following chemical structure:
• Chemical name:
• Benzeneacetamide, N -ethyl-α-(hydroxymethyl)- N -(4-pyridinylmethyl)- Each mL contains:
• Active:
• tropicamide 5 mg (0.5%) or 10 mg (1%);
• Inactives: boric acid, hydrochloric acid, edetate disodium dihydrate, purified water.
• Sodium hydroxide and/or hydrochloric acid (to adjust pH) pH range 4.0 - 5.8.
• Preservative: benzalkonium chloride 0.01%.
• ChemStructure-Tropicamide.jpg

Quoted from the official label, section “Description”.

Ingredients people check for

Lactose, gluten, dyes, sugars and other ingredients that matter with an allergy, intolerance or diet — as this product’s FDA label lists them.

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

Details

Source: NDC Directory · 2026-09-13 · not reviewed by a clinician

Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).

Report wrong or outdated information on this page

Other strengths and forms

6 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.

See every product with Tropicamide